Abstract

Background and importanceCT-P13 is an infliximab biosimilar that received market authorisation in the European Union in 2013. CT-P13 has undeniable cost-saving opportunities and extensive literature supporting its equivalence to originator...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Exploring the Reasons Behind the Substantial Discontinuation Rate Among Patients Taking CT-P13 in a Large Tertiary Hospital in Western Switzerland: A Retrospective Cohort Study Using Routinely Collected Medical Data.
Marko Krstic ... Joachim Marti
Drugs - Real World Outcomes | VOL. 9
Marko Krstic, et. al.Marko Krstic ... Joachim Marti
19 May 2022
P536 Comparison of outcomes of infliximab biosimilar CT-P13 with infliximab originator in patients with inflammatory bowel disease
I Yüksel ... I E Guven
Journal of Crohn's and Colitis | VOL. 16
I Yüksel, et. al.I Yüksel ... I E Guven
21 Jan 2022
Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
Yoon-Kyoung Sung ... Seung-Jae Hong
Rheumatology International | VOL. 37
Yoon-Kyoung Sung, et. al.Yoon-Kyoung Sung ... Seung-Jae Hong
18 Feb 2017
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain.
Helena Martínez-Lozano ... Lucía Relea Pérez
Revista Española de Enfermedades Digestivas | VOL. 113
Helena Martínez-Lozano, et. al.Helena Martínez-Lozano ... Lucía Relea Pérez
01 Jan 2020
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C
Amélie Kinet-Poleur ... Mélanie Closset
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Amélie Kinet-Poleur, et. al.Amélie Kinet-Poleur ... Mélanie Closset
31 Jul 2024
Appropriate therapeutic drug monitoring of vancomycin improves outcomes of patients with bacterial infection in ICU
Xiaohua Zhou ... Hongjian Ji
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Xiaohua Zhou, et. al.Xiaohua Zhou ... Hongjian Ji
30 Jul 2024
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia
Emine Ecem Kilinc ... Murat Akova
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Emine Ecem Kilinc, et. al.Emine Ecem Kilinc ... Murat Akova
24 Jul 2024
Cleaning validation for blister packaging machines in hospital-supplying pharmacies
Dominic Fenske ... Stephanie Zergiebel
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Dominic Fenske, et. al.Dominic Fenske ... Stephanie Zergiebel
23 Jul 2024
View more papers